Lpl Financial LLC Bio Line Rx Ltd. Transaction History

Lpl Financial LLC

$196 Billion
Q2 2024

A detailed history of Lpl Financial LLC transactions in Bio Line Rx Ltd. stock. As of the latest transaction made, Lpl Financial LLC holds 82,000 shares of BLRX stock, worth $37,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares

82,000

Previous 100,323 18.26%

Holding current value

$37,720

Previous $112,000 58.93%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$0.56 - $0.86 $10,260 - $15,757	-18,323 Reduced 18.26%	82,000 $46,000
Q4 2023 Feb 14, 2024	SELL	$1.31 - $1.86 $17,536 - $24,899	-13,387 Reduced 11.77%	100,323 $157,000
Q3 2023 Nov 13, 2023	SELL	$1.23 - $2.45 $14,145 - $28,175	-11,500 Reduced 9.18%	113,710 $206,000
Q2 2023 Jul 31, 2023	BUY	$0.96 - $1.78 $7,200 - $13,350	7,500 Added 6.37%	125,210 $200,000
Q4 2022 Feb 07, 2023	BUY	$0.57 - $0.95 $40,546 - $67,577	71,134 Added 152.73%	117,710 $69,000
Q3 2022 Nov 14, 2022	SELL	$0.88 - $1.91 $3,520 - $7,640	-4,000 Reduced 7.91%	46,576 $43,000
Q2 2022 Aug 12, 2022	SELL	$1.06 - $1.82 $19,080 - $32,760	-18,000 Reduced 26.25%	50,576 $65,000
Q1 2022 May 16, 2022	SELL	$1.46 - $2.18 $7,300 - $10,900	-5,000 Reduced 6.8%	68,576 $117,000
Q4 2021 Feb 14, 2022	BUY	$1.98 - $3.06 $14,850 - $22,950	7,500 Added 11.35%	73,576 $150,000
Q1 2021 May 14, 2021	BUY	$2.38 - $4.0 $55,216 - $92,800	23,200 Added 54.11%	66,076 $184,000
Q4 2020 Feb 12, 2021	BUY	$1.47 - $3.62 $38,220 - $94,120	26,000 Added 154.06%	42,876 $108,000
Q3 2020 Nov 09, 2020	SELL	$1.56 - $2.37 $4,680 - $7,110	-3,000 Reduced 15.09%	16,876 $28,000
Q2 2020 Aug 13, 2020	BUY	$1.23 - $2.39 $11,070 - $21,510	9,000 Added 82.75%	19,876 $34,000
Q1 2020 May 14, 2020	BUY	$1.11 - $2.6 $12,072 - $28,277	10,876 New	10,876 $14,000

Others Institutions Holding BLRX

# of Institutions

Shares Held

4.29M

Call Options Held

49.9K

Put Options Held

122K

View Full List

About BioLineRx Ltd.

Ticker BLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,524,500
Market Cap $28.3M
Description
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...

More about BLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Bio Line Rx Ltd. Transaction History